Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,465 | -13,294 | -13,900 | -16,235 | -21,436 |
| Depreciation Amortization | 36 | 35 | N/A | 1 | 7 |
| Other Working Capital | 942 | 641 | -1,072 | -804 | 2,541 |
| Other Operating Activity | 1,886 | 1,770 | 4,793 | 1,146 | 2,479 |
| Operating Cash Flow | $-20,601 | $-10,848 | $-10,179 | $-15,892 | $-16,409 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 263 | 50,469 | 15,379 | 3,583 | 5,925 |
| Dividend Paid | N/A | -394 | N/A | N/A | N/A |
| Financing Cash Flow | $263 | $50,075 | $15,379 | $3,583 | $5,925 |
| Beginning Cash Position | 47,480 | 8,253 | 3,053 | 15,362 | 25,846 |
| End Cash Position | 27,142 | 47,480 | 8,253 | 3,053 | 15,362 |
| Net Cash Flow | $-20,338 | $39,227 | $5,200 | $-12,309 | $-10,484 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,601 | -10,848 | -10,179 | -15,892 | -16,409 |
| Free Cash Flow | -20,601 | -10,848 | -10,179 | -15,892 | -16,409 |